Pathophysiology of coronary artery disease

P Libby, P Theroux - Circulation, 2005 - Am Heart Assoc
During the past decade, our understanding of the pathophysiology of coronary artery
disease (CAD) has undergone a remarkable evolution. We review here how these advances …

Standards of medical care in diabetes

American Diabetes Association - Diabetes care, 2005 - search.proquest.com
Abstract The American Diabetes Association standards of medical care in diabetes are
presented. They are intended to provide clinicians, patients, researchers, payors, and other …

Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication

RC Kessler, P Berglund, O Demler, R Jin… - Archives of general …, 2005 - jamanetwork.com
Context Little is known about lifetime prevalence or age of onset ofDSM-IVdisorders.
Objective To estimate lifetime prevalence and age-of-onset distributions ofDSM-IVdisorders …

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

ES Unit - Lancet, 2005 - thelancet.com
Background Results of previous randomised trials have shown that interventions that lower
LDL cholesterol concentrations can significantly reduce the incidence of coronary heart …

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

JC LaRosa, SM Grundy, DD Waters… - … England Journal of …, 2005 - Mass Medical Soc
Background Previous trials have demonstrated that lowering low-density lipoprotein (LDL)
cholesterol levels below currently recommended levels is beneficial in patients with acute …

C-reactive protein levels and outcomes after statin therapy

PM Ridker, CP Cannon, D Morrow… - … England Journal of …, 2005 - Mass Medical Soc
Background Statins lower the levels of low-density lipoprotein (LDL) cholesterol and C-
reactive protein (CRP). Whether this latter property affects clinical outcomes is unknown …

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

TR Pedersen, O Faergeman, JJP Kastelein, AG Olsson… - Jama, 2005 - jamanetwork.com
ContextEvidence suggests that more intensive lowering of low-density lipoprotein
cholesterol (LDL-C) than is commonly applied clinically will provide further benefit in stable …

[HTML][HTML] Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

SE Nissen, EM Tuzcu, P Schoenhagen… - … England Journal of …, 2005 - Mass Medical Soc
Background Recent trials have demonstrated better outcomes with intensive than with
moderate statin treatment. Intensive treatment produced greater reductions in both low …

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

CT Trialists - The Lancet, 2005 - Elsevier
BACKGROUND: Results of previous randomised trials have shown that interventions that
lower LDL cholesterol concentrations can significantly reduce the incidence of coronary …

Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study

N Takaya, C Yuan, B Chu, T Saam, NL Polissar… - Circulation, 2005 - Am Heart Assoc
Background—Previous studies suggest that erythrocyte membranes from intraplaque
hemorrhage into the necrotic core are a source of free cholesterol and may become a …